Saudi Arabia Biotechnology Market to Grow with a CAGR of 3.78% through 2030
Surge in research and development activities is
expected to drive the Saudi Arabia Biotechnology Market growth in the forecast
period, 2026-2030.
According to TechSci Research report, “Saudi Arabia
Biotechnology Market - By Region and Competition, Forecast & Opportunities,
2030F”, the Saudi Arabia Biotechnology Market stood at USD 224.36 Million in
2024 and is anticipated to grow with a CAGR of 3.78% through 2030. Initiatives
taken by government based on biotechnology has led to favorable market
conditions for the Saudi Arabia Biotechnology Market. Several factors
contribute to the growth of various biotechnology products.
One of the most prominent areas of R&D activity in
Saudi Arabia is healthcare. The Kingdom is investing heavily in medical
research to improve disease prevention, diagnostics, and treatment, with a
particular focus on chronic conditions such as diabetes, cardiovascular
diseases, and cancer. In response to rising healthcare demands, Saudi Arabia is
leveraging biotechnology to develop advanced therapeutic options, including
personalized medicine, gene therapies, and targeted treatments. The increased
focus on healthcare innovation has prompted biotech firms to expand their
R&D efforts, creating opportunities for new discoveries that can have
significant local and global impacts.
Saudi Arabia has established dedicated biotech zones aimed at creating a thriving ecosystem for biotechnology companies. The King Abdullah Economic City (KAEC) and other special economic zones (SEZs) are designed to attract global biotech companies, providing them with access to state-of-the-art infrastructure, tax incentives, and streamlined administrative processes.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Saudi Arabia Biotechnology Market”
The Saudi Arabia Biotechnology Market is segmented
into product type, technology, regional distribution, and company.
Based on Product Type, Reagents have
emerged as the dominating segment in the Saudi Arabia Biotechnology Market in
2024. One of the key drivers behind the
prominence of reagents is the rapid expansion of healthcare infrastructure in
Saudi Arabia. With the country's focus on improving its healthcare sector,
including the establishment of advanced laboratories, diagnostic centers, and
medical research facilities, there is a heightened demand for reagents used in
laboratory tests and diagnostic procedures. Reagents are crucial for accurate
testing, detection, and monitoring of diseases, particularly in areas such as
cancer, infectious diseases, and genetic disorders, which are key health
priorities in the kingdom.
Based on Region, Western have emerged as the fastest
growing region in the Saudi Arabia Biotechnology Market in 2024. The Western
region has seen an increase in private sector involvement in biotechnology,
driven by demand for innovative healthcare solutions, pharmaceutical products,
and medical technologies. This has spurred the growth of biotech startups and
has encouraged investment from venture capital firms looking to tap into this
expanding market.
Major companies
operating in Saudi Arabia Biotechnology Market are:
- Saudi Biotechnology Manufacturing Co
- Amgen Middle East FZ LLC
- SaudiVax
- Lifera Omics
- Novartis Saudi Arabia
Download Free Sample Report
Customers can also request for 10% free
customization on this report
“Nanotechnology is making significant strides in
healthcare, where it is being applied in drug delivery systems, diagnostic
tools, and medical devices. In particular, nanomedicine is gaining traction,
offering innovative solutions for targeted drug delivery, minimizing side
effects, and enhancing therapeutic efficacy. Saudi Arabia's biotechnology
market is increasingly exploring nanomaterials such as nanoparticles, which are
used to deliver drugs with high precision to specific cells or tissues, a
critical development in the treatment of cancer, cardiovascular diseases, and
other complex conditions”, said Mr. Karan Chechi, Research Director of TechSci
Research, a research-based management consulting firm.
“Saudi Arabia Biotechnology Market By Product
Type (Instruments, Reagents, Software and Services), By Technology
(Nanobiotechnology, Tissue Engineering and Regeneration, DNA Sequencing,
Cell-Based Assays, Fermentation, PCR Technology, Chromatography, Other), By
Region, Competition, Forecast & Opportunities, 2020-2030F”, has evaluated
the future growth potential of Saudi Arabia Biotechnology Market and provides
statistics & information on market size, structure, and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Saudi Arabia Biotechnology Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com